The newly opened ICON
is located on the LMU campus Großhadern/Martinsried. | © LMU
Cardiovascular diseases are the most common cause of death in Germany. And many illnesses that affect the heart and its vessels have a metabolic origin, at least in part. Accordingly, strategies aimed at preventing or treating diseases such as heart attacks, diabetes, and strokes must always take metabolic causes into consideration.
The newly opened Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICON) on the LMU Grosshadern/Martinsried Campus concentrates interdisciplinary research related to diseases of the cardiovascular system in one place and will bring innovative therapeutic approaches from research to clinical application.
A unique research concept in Europe, state-of-the-art technical facilities, and work on optimized large animal models offer ideal conditions for practice-oriented innovation. ICON's facilities are particularly excellent when it comes to imaging techniques, surgical equipment, and animal housing. ICON is the sixth research building at LMU to be funded by the German federal government and the Free State of Bavaria since the corresponding program began in 2007. The overall costs of 63 million euros are being shared by the German federal government and the Free State of Bavaria, supplemented by co-financing between LMU and LMU University Hospital.
